Urge your representatives in Congress to support its programs to increase access to vaccines around the world.

The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that certain groups get two doses, spaced six months ...

Immunocompromised people and those who are over 65 years of age or older should get a second dose of this year’s COVID-19 ...

Galleries and museums are displaying works that depict climate change and its brutality for ecosystems. For the artists, they ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Shares of Moderna Inc. MRNA inched 0.55% higher to $53.09 Friday, on what proved to be an all-around mixed trading session ...

Moderna shares rebound after six days of losses. Analysts mixed on stock with Strong Sell rating but potential for future growth.

Total revenues of $667.9 million ($663.2 million on an adjusted basis) compared to $601.7 million ($603.7 million on an adjusted basis) in the prior year quarter Net income of $30.1 million ($33.1 mil ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Volunteers are currently being sought in Japan, Canada, Australia and the UK for a clinical trial to develop the world's ...

Health officials are concerned millions of people with health issues aren't taking up vaccination offers as UK faces a triple ...

Singapore’s Health Ministry (MOH) will roll out the updated JN.1 Pfizer-BioNTech/Comirnaty and JN.1 Moderna/Spikevax vaccines ...